COMP <GO>
CELU vs SHPH // EV/EBITDA & P/E VALUATION
Celularity Inc. (Class A) (NASDAQ) VS. Shuttle Pharmaceuticals Holdings Inc. (NASDAQ) • 15-METRIC TALLY: CELU 1
— SHPH 1
■ METRIC PARITY
LAST: $0.85 (-9.66%) • MKT CAP: $27.6M
valuation
—
LAST: $5.23 (-0.19%) • MKT CAP: $24.9M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CELU VS. SHPH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CELU | SHPH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -51.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 1/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.9 | 58.0 | -22.09 | SHPH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.6M | $24.9M | $2.6M | CELU | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CELU REV | SHPH REV | CELU GROSS % | SHPH GROSS % | CELU FCF | SHPH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $26.6M | $0 | 24.4% | — | -$13.3M | -$9.5M |
| FY 2024 | $54.2M | $0 | 72.4% | — | -$6.6M | -$7.3M |
| FY 2023 | $22.8M | $0 | — | — | -$38.7M | -$5.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CELU // BETA —
SHPH // BETA —